[Skip to Navigation]
Sign In

October 2021 - April 2016

Decade

Year

Issue

November 2019, Vol 4, No. 11, Pages 1059-1180

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1059. doi:10.1001/jamacardio.2018.3225
Original Investigation

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Cardiol. 2019;4(11):1067-1075. doi:10.1001/jamacardio.2019.3502

This prespecified analysis of a randomized clinical trial analyzes whether inclisiran, a small interfering RNA, reduces mean low-density lipoprotein cholesterol exposure with an infrequent dosing regimen.

Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1077-1083. doi:10.1001/jamacardio.2019.3221

This study evaluates data from the New York Percutaneous Intervention Reporting System to assess the association between reported risk-adjusted hospital percutaneous coronary intervention (PCI)–related mortality and a hospital’s future PCI-related mortality.

Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly Adults

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1084-1091. doi:10.1001/jamacardio.2019.3511

This cohort study assesses whether the addition of frailty measures to traditional comorbidity-based risk-adjustment models improved prediction of outcomes in patients with acute myocardial infarction, heart failure, and pneumonia.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1092-1101. doi:10.1001/jamacardio.2019.3355

This secondary analysis of the GLOBAL LEADERS randomized clinical trial evaluates the benefit and risks of aspirin in addition to ticagrelor among patients with acute coronary syndrome beyond 1 month after percutaneous coronary intervention.

Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals

Abstract Full Text
open access
JAMA Cardiol. 2019;4(11):1102-1111. doi:10.1001/jamacardio.2019.3593

This cohort study examines trends in outcomes and mortality rates for UK patients with a new heart failure diagnosis.

Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2019;4(11):1112-1121. doi:10.1001/jamacardio.2019.3345

This cohort study evaluates if mild echocardiographic pulmonary hypertension is associated with reduced right ventricular function and increased risk of mortality.

Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1122-1128. doi:10.1001/jamacardio.2019.3604

This study investigates how pragmatic or explanatory cardiovascular randomized clinical trials are and if this has changed over time.

Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1131-1138. doi:10.1001/jamacardio.2019.3665

This study compares the sensitivity, specificity, and estimated number needed to treat to prevent 1 atherosclerotic cardiovascular disease event in 10 years according to statin criteria from 5 major guidelines.

Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Left-Sided Heart Valve Surgery

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1139-1147. doi:10.1001/jamacardio.2019.3649

This cohort study of Danish national registries assesses the long-term risk of thromboembolism in patients developing new-onset postoperative atrial fibrillations after isolated left-sided heart valve surgery relative to patients with nonsurgical nonvalvular atrial fibrillation.

Brief Report

Patient and Hospital Characteristics of Mitral Valve Surgery in the United States

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1149-1155. doi:10.1001/jamacardio.2019.3659

This cross-sectional study evaluates the hospital, patient, and procedural characteristics of mitral valve repair or replacement in the United States.

Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1156-1159. doi:10.1001/jamacardio.2019.3903

This study compares the incidence of aortic valve stenosis in patients with familial hyperlipidemia with the incidence in the total population, using a Norwegian population cohort.

Research Letter

Implications of Specialist Density for Diabetes Care in the United States

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1174-1175. doi:10.1001/jamacardio.2019.3796

This Research Letter examines the distribution of US internal medicine specialists who are able to provide diabetes care.

From the Heart

Predictions

Abstract Full Text
JAMA Cardiol. 2019;4(11):1063-1064. doi:10.1001/jamacardio.2019.3311

This essay describes the author’s challenges in predicting treatment courses for patients.

Editorial

Death to Mortality as a Reported Percutaneous Coronary Intervention Quality Metric

Abstract Full Text
JAMA Cardiol. 2019;4(11):1065-1066. doi:10.1001/jamacardio.2019.3232
Invited Commentary

Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide

Abstract Full Text
has audio
JAMA Cardiol. 2019;4(11):1075-1076. doi:10.1001/jamacardio.2019.3528

Consequences of Slow Progress Toward Pragmatism in Randomized Clinical Trials: It Is Time to Get Practical

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1129-1130. doi:10.1001/jamacardio.2019.3922

Postoperative and Nonvalvular Atrial Fibrillation—Not So Different After All

Abstract Full Text
JAMA Cardiol. 2019;4(11):1147-1148. doi:10.1001/jamacardio.2019.3826

Optimizing the Physician Workforce for Care of Patients With Type 2 Diabetes

Abstract Full Text
JAMA Cardiol. 2019;4(11):1175-1177. doi:10.1001/jamacardio.2019.3827
Review

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials

Abstract Full Text
JAMA Cardiol. 2019;4(11):1160-1169. doi:10.1001/jamacardio.2019.3066

This systematic review synthesizes the literature on patient-focused and physician-oriented interventions aimed at increasing statin-prescribing rates in adults without a history of cardiovascular disease.

JAMA Cardiology Clinical Challenge

Syncope After Percutaneous Coronary Intervention

Abstract Full Text
has active quiz
JAMA Cardiol. 2019;4(11):1170-1171. doi:10.1001/jamacardio.2019.3306

A man in his late 50s with a history of remote coronary artery bypass grafting presents with unstable angina and experiences worsening exertional dyspnea and multiple episodes of syncope after undergoing percutaneous coronary intervention with a drug-eluting stent. What would you do next?

Cardiovascular Images

A Man in His Early 70s With Aortic Stenosis and Discoloration of the Aortic Valve

Abstract Full Text
JAMA Cardiol. 2019;4(11):1172. doi:10.1001/jamacardio.2019.3301

This case report describes a man in his early 70s with black discoloration of the aortic valve.

Comment & Response

Are Antiplatelet Agents Beneficial in Prevention of Infective Endocarditis?

Abstract Full Text
JAMA Cardiol. 2019;4(11):1177. doi:10.1001/jamacardio.2019.3130

Are Antiplatelet Agents Beneficial in Prevention of Infective Endocarditis?—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(11):1177-1178. doi:10.1001/jamacardio.2019.3089

Substantial Differences Between Cohorts of Patients Hospitalized With Heart Failure in Canada and the United States

Abstract Full Text
JAMA Cardiol. 2019;4(11):1178-1179. doi:10.1001/jamacardio.2019.3314

Substantial Differences Between Cohorts of Patients Hospitalized With Heart Failure in Canada and the United States—Reply

Abstract Full Text
JAMA Cardiol. 2019;4(11):1179. doi:10.1001/jamacardio.2019.3317
Correction

Error in Figure

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1179. doi:10.1001/jamacardio.2019.3245

Error in Figure

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1179-1180. doi:10.1001/jamacardio.2019.3757

Error in Figure 1

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1180. doi:10.1001/jamacardio.2019.3881

Error in Strengths/Limitations Section

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1180. doi:10.1001/jamacardio.2019.4782
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2019;4(11):1061. doi:10.1001/jamacardio.2018.3226
×